A Clinical Study Comparing the Bioequivalence of IBI3027 and DUPIXENT®(Dupilumab) in Healthy Chinese Volunteers
Clinical trial NCT07502534 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07502534
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-24
- Primary completion
- 2026-07-07
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.